Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Oncology November 09,2024 0

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Oncology November 09,2024 0

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Oncology November 09,2024 0

Immune cell discovery offers new potential for cancer immunotherapy

byEmory UniversityProposed models of T cell differentiation states in TDLNs. Credit:Nature(2024). DOI: 10.1038/s41586-024-08076-7Researchers at Winship Cancer Institute of Emory Univ

Oncology November 09,2024 0

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit

Oncology November 09,2024 0

Researchers discover key genetic mutations in bowel cancer cells that lead to resistance to WRN inhibitors

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainResearchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibit

Oncology November 09,2024 0

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines

Oncology November 09,2024 0

Unlocking the potential of bispecific antibody-drug conjugates for targeted cancer therapy

by Frontiers JournalsCredit: Unsplash/CC0 Public DomainAntibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines

Oncology November 09,2024 0

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Oncology November 09,2024 0

Metformin for rare skin cancer treatment: Research shows drug's unique ability to impact immune pathways

by Tsinghua University PressThis schematic illustrates the process of developing patient-derived skin tumor organoids from Dermatofibrosarcoma Protuberans (DFSP). The workflow includes organoid cultur

Oncology November 09,2024 0

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in

Oncology November 09,2024 0

Cancer detection recovered following pandemic disruptions

by Lori SolomonOverall, cancer detection in the United States recovered meaningfully in 2021 following substantial disruptions in 2020, according to a studypublishedonline Oct. 14 in

Oncology November 09,2024 0

Polyploidy study reveals why some cancers are resistant to therapeutic drugs

byOsaka UniversityOverview of the study. (A) We created unique cells with double the usual number of chromosomes to investigate the relationship between polyploidy and DNA damage. (B) After trea

Oncology November 09,2024 0

Polyploidy study reveals why some cancers are resistant to therapeutic drugs

byOsaka UniversityOverview of the study. (A) We created unique cells with double the usual number of chromosomes to investigate the relationship between polyploidy and DNA damage. (B) After trea

Oncology November 09,2024 0

Performance in physical tests can help manage treatment for metastatic lung cancer

byFAPESPCredit: Unsplash/CC0 Public DomainA study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their performance in simple physical

Oncology November 09,2024 0

Performance in physical tests can help manage treatment for metastatic lung cancer

byFAPESPCredit: Unsplash/CC0 Public DomainA study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their performance in simple physical

Oncology November 09,2024 0

D:\每日资讯\肿瘤学与癌症_资讯\乳腺癌：为什么难以治疗，哪些新方法即将出现.docx

Breast cancer: Why it's difficult to treat and what new approaches are on the horizonby Anna-Mart Engelbrecht,The ConversationCredit: Unsplash/CC0 Public DomainBreast cancer is the number on

Oncology November 09,2024 0

D:\每日资讯\肿瘤学与癌症_资讯\乳腺癌：为什么难以治疗，哪些新方法即将出现.docx

Breast cancer: Why it's difficult to treat and what new approaches are on the horizonby Anna-Mart Engelbrecht,The ConversationCredit: Unsplash/CC0 Public DomainBreast cancer is the number on

Oncology November 09,2024 0

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Oncology November 09,2024 0

Updated colorectal cancer screening effective for adults 45–50, study suggests

byKaiser PermanenteCredit: Pixabay/CC0 Public DomainThe updated national colorectal cancer screening guidelines that recommend screening begin at age 45—rather than 50—can benefit younger adults

Oncology November 09,2024 0